← Back to Search

Behavioral Intervention

Experimental: 3RP treatment for Stress (ASD Trial)

N/A
Waitlist Available
Research Sponsored by Massachusetts General Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change between baseline (week 0) to post intervention (week 12)
Awards & highlights

ASD Trial Summary

This study has three aims: Phase I: Through focus group interviews with expert clinicians, leaders of organizations, and parents with children with ASD, this study aims to identify the psychosocial needs of parents of children with ASD, specifically a) the types of concerns that parents find most difficult and stressful b) areas of concern that lack support and resources, and c) areas of need for education and skill training. This study also aims to gather feedback on the Benson-Henry Institute's Relaxation Response Resiliency Program (3RP). Phase II: Informed by Phase I findings, this study aims to develop and determine the feasibility and acceptability of a virtual 8-session Relaxation Response Resiliency (3RP) program for parents of children with ASD. Phase II: This study also aims to test the effectiveness of a pilot wait-list control trial, establishing efficacy of a virtual resiliency program.

Eligible Conditions
  • Stress

ASD Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change between baseline (week 0) to post intervention (week 12)
This trial's timeline: 3 weeks for screening, Varies for treatment, and change between baseline (week 0) to post intervention (week 12) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Distress
Resiliency
Stress Reactivity/Coping
Secondary outcome measures
Stress Reactivity

ASD Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Experimental: 3RP treatmentExperimental Treatment1 Intervention
An adapted version of the Relaxation Response Resiliency Program (3RP) for parents of children with ASD. The adapted program incorporates the three prongs of the 3RP: RR elicitation, stress awareness, and adaptive strategies. Experimental arm participated in the 8-week 3RP program starting immediately after enrollment.
Group II: Waitlist controlActive Control1 Intervention
An adapted version of the Relaxation Response Resiliency Program (3RP) for parents of children with ASD. The adapted program incorporates the three prongs of the 3RP: RR elicitation, stress awareness, and adaptive strategies. The waitlist arm participated in the 8-week 3RP program starting 3 months after enrollment.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Relaxation Response Resiliency Program for Parents of Children with ASD
2016
N/A
~70

Find a Location

Who is running the clinical trial?

Massachusetts General HospitalLead Sponsor
2,925 Previous Clinical Trials
13,197,840 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Development of a Resiliency Training Program for Parents of Children With Autism Spectrum Disorder
Karen Kuhlthau 2016. "Development of a Resiliency Training Program for Parents of Children With Autism Spectrum Disorder". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT02995408.
~8 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top